Binding Term Sheet - Supply ConfidentialConfidential • October 21st, 2014 • Response Biomedical Corp • Services-testing laboratories
This binding term sheet (this “Binding Term Sheet”), dated as of October 15, 2014, is between Response Biomedical Corp., having its principle address at 1781-75th Avenue W., Vancouver, B.C., Canada V6P 6P2 (“Response”), and 杭州中翰盛泰生物技术有限公司, HANGZHOU JOINSTAR BIOMEDICAL TECHNOLOGY CO., LTD, having its registered address at Floor 10, Main Building, #519 Xingguo RD, Qianjiang Economic Development Zone, Hangzhou, Zhejiang Province, China (“JBT”) for supply by Response of raw materials for multiple Assays that will run on a New Analyzer developed by JBT. This Binding Term Sheet is intended to be a binding agreement between the parties until such time as the parties enter into Supply Agreement that more fully state the agreements between the parties with respect to the transactions described herein.
Binding Term Sheet - Equity Investment (HZLZ) ConfidentialResponse Biomedical Corp • October 21st, 2014 • Services-testing laboratories • British Columbia
This Binding Term Sheet - Equity Investment (HZLZ) (this “Binding Term Sheet”), dated as of October 15th, 2014, is between 杭州丽珠医疗器械有限公司Hangzhou Lizhu Medical Instrument & Reagent Co., Ltd，注册地址为2F, Building 6, #188-200, Moganshan Road, Hangzhou, Zhejiang, China (“HZLZ”) and Response Biomedical Corp., having its principle address at 1781-75th Avenue W., Vancouver, B.C., Canada V6P 6P2 (“Response”), and sets forth the terms with respect to the investment in Response equity by HZLZ. This Binding Term Sheet is intended to be a binding agreement between the parties until such time as the parties enter into Subscription Agreement that more fully state the agreements between the parties with respect to the transactions described herein.
TECHNOLOGY DEVELOPMENT AGREEMENTTechnology Development Agreement • October 21st, 2014 • Response Biomedical Corp • Services-testing laboratories
This Technology Development Agreement (this “Technology Development Agreement”) is made and entered into as of October 15, 2014 (the “Effective Date”), by and between Response Biomedical Corp., a corporation organized under the laws of British Columbia and having a place of business at 1781-75th Avenue W., Vancouver, B.C., Canada V6P 6P2 (“Response”), and 杭州中翰盛泰生物技术有限公司, Hangzhou Joinstar Biomedical Technology Co., Ltd., a corporation organized under the laws of People’s Republic of China and having its registered address at Floor 10, Main Building, #519 Xingguo RD, Qianjiang Economic Development Zone, Hangzhou, Zhejiang Province, China (“JBT”). In this Technology Development Agreement, Response and JBT may each be referred to as a “Party” and collectively as the “Parties.”
